EuclidSR Partners

EuclidSR Partners was a venture capital firm that specialized in early-stage investments within the life sciences and healthcare information technology sectors. The firm was established as a strategic partnership between Euclid Partners and SR One, the corporate venture capital arm of GlaxoSmithKline. EuclidSR Partners focused on identifying high-growth opportunities in biotechnology, pharmaceuticals, and medical devices, providing portfolio companies with both capital and strategic industry insights. During its active period in the early 2000s, the firm played a significant role in bridging the gap between independent venture capital and corporate pharmaceutical interests. It is currently considered an inactive or legacy entity in the venture capital landscape.